People who have cancer might have the disease treated with several therapies, including chemotherapy and radiation. Radiation therapy, which more than half of all people with cancer receive as part of their treatment, uses ...
Jul 27, 2023
0
13
Anxiety disorders are common among Australian children, affecting nearly 7% of those aged 4–11 years.
Jul 24, 2023
0
6
In an effort to improve treatment outcomes and quality of life for older adults with cancer, researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States, and colleagues ...
Jul 17, 2023
0
18
As of July 1, authorized psychiatrists have been allowed to prescribe MDMA (the chemical found in "ecstasy") to treat post-traumatic stress disorder (PTSD), and psilocybin (found in "magic mushrooms") to treat depression ...
Jul 5, 2023
0
2
Scientists at St. Jude Children's Research Hospital found immune and tumor cells compete over glutamine, a major nutrient in their local environment, with significant implications for anti-cancer activity. If cancer cells ...
Jul 5, 2023
0
27
Evidence from a small-scale clinical trial suggests that a variation of the advanced blood cancer immunotherapy known as CAR-T could be adapted to treat myasthenia gravis, an autoimmune disorder of the nervous system. The ...
Jun 22, 2023
0
51
A new distributional cost-effectiveness analysis of gene therapy versus standard-of-care for sickle cell disease (SCD) found that while gene therapy is cost-ineffective by conventional measures, it can be an equitable therapeutic ...
May 29, 2023
0
4
Cutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with more common approaches such as chemotherapy. But determining the best treatment combination isn't always straightforward. ...
May 12, 2023
0
32
Type I interferon, a protein that is important for the body's defense against viruses, plays a critical role in suppressing inflammation in mice infected with the schistosome parasite, Penn State immunology researchers have ...
May 5, 2023
1
119
Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to ...
May 4, 2023
0
6
